Related Experiment Video
Updated: Apr 23, 2026
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.2K
FoxO3a and disease progression
Richard Seonghun Nho1, Polla Hergert1
1Richard Seonghun Nho, Polla Hergert, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, United States.
World Journal of Biological Chemistry
|September 17, 2014
Summary
Forkhead box O (FoxO) transcription factors regulate vital cellular functions. This review focuses on FoxO3a, a key regulator of cell proliferation, apoptosis, and metabolism, and its role in disease.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The Forkhead box O (FoxO) family are transcriptional regulators crucial for diverse cellular functions.
- Four FoxO proteins (FoxO1, FoxO3a, FoxO4, FoxO6) are identified in humans.
- FoxO3a is extensively studied for its unique role in regulating cell proliferation, apoptosis, metabolism, stress management, and longevity.
Purpose of the Study:
- To review the function of FoxO3a in disease progression.
- To explore the regulatory mechanisms of FoxO3a.
- To discuss FoxO3a as a potential therapeutic target for various diseases.
Main Methods:
- Literature review of existing studies on FoxO3a.
- Analysis of FoxO3a's regulatory pathways.
- Examination of FoxO3a's involvement in disease pathogenesis.
Main Results:
- FoxO3a plays a pivotal role in cell proliferation, apoptosis, metabolism, stress response, and longevity.
- Alterations in FoxO3a are linked to the progression of cancers, fibrosis, and other diseases.
- FoxO3a exhibits complex regulatory mechanisms influencing cellular homeostasis.
Conclusions:
- FoxO3a is a critical regulator with significant implications in disease development.
- Understanding FoxO3a's mechanisms offers insights into disease pathogenesis.
- Targeting FoxO3a presents a promising therapeutic strategy for multiple diseases.
More Related Videos
Related Concept Videos
02:07Tumor Progression
3.1K
3.1K
02:07Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
03:03mTOR Signaling and Cancer Progression
1.5K
1.5K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K